Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Division of Interventional Radiology, Joint Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
J Am Coll Surg. 2021 Feb;232(2):195-201. doi: 10.1016/j.jamcollsurg.2020.09.019. Epub 2020 Sep 30.
Acute cholecystitis in nonsurgical candidates is often managed with cholecystostomy tube drainage. After symptom resolution, management options include cholecystectomy, long-term tube drainage, or tube removal. Percutaneous cholecystolithotomy (PCCL) can offer another therapeutic option for patients who are poor operative candidates.
A retrospective study of PCCL performed between December 2000 and September 2017 was conducted. Demographic characteristics, procedure details, gallstone-related complications, procedure-related complications, readmission, and mortality data were collected.
Seventy-five patients were identified (52.0% male, 48.0% female, mean ± SD age 75.6 ± 13.9 years). Mean ± SD follow-up time was 2.8 ± 3.7 years. Most of the patients (90.7%) had an American Society of Anesthesiologists physical status classification of 3 or 4. Eleven patients (14.7%) had failed earlier cholecystectomy. A total of 96 PCCL procedures were performed, and complete gallstone removal was achieved in 68 of 75 patients (90.7%), including all patients with previously aborted cholecystectomy. The 30-day and 90-day readmission rates were 4% and 8%, respectively. Three patients (3.9%) subsequently underwent cholecystectomy after PCCL. Ten (10.4%) procedure-related complications (Clavien-Dindo grade I and II) and 17 (22.7%) gallstone-related complications occurred during the follow-up period. Postprocedural choledocholithiasis occurred in 6 patients (8.0%). Recurrent gallstones developed in 5 patients (6.3%) (3 patients undergoing cholecystectomy and 2 patients treated with cholecystostomy tube).
PCCL is a viable option for management of symptomatic gallbladder stones in high-risk surgical patients. There is a high technical success rate, even in patients with earlier failed cholecystectomy. Most patients (77.3%) avoided gallstone-related complications after the procedure.
对于非手术适应证的急性胆囊炎患者,通常采用胆囊造瘘管引流进行治疗。在症状缓解后,可选择胆囊切除术、长期引流管或拔管等治疗方案。对于手术风险较高的患者,经皮胆囊碎石术(PCCL)也可为其提供另一种治疗选择。
本研究回顾性分析了 2000 年 12 月至 2017 年 9 月期间行 PCCL 的患者。收集患者的人口统计学特征、手术细节、与胆囊结石相关的并发症、与手术相关的并发症、再入院和死亡率数据。
共纳入 75 例患者(52.0%为男性,48.0%为女性,平均年龄 75.6±13.9 岁)。平均随访时间为 2.8±3.7 年。大多数患者(90.7%)的美国麻醉医师协会(ASA)身体状况分级为 3 级或 4 级。11 例(14.7%)患者曾行胆囊切除术失败。共进行了 96 次 PCCL 手术,75 例患者中有 68 例(90.7%)成功取出了全部胆囊结石,包括所有先前胆囊切除术失败的患者。术后 30 天和 90 天的再入院率分别为 4%和 8%。3 例(3.9%)患者在 PCCL 后行胆囊切除术。10 例(10.4%)患者发生与手术相关的并发症(Clavien-Dindo Ⅰ级和Ⅱ级),17 例(22.7%)发生与胆囊结石相关的并发症。6 例(8.0%)患者术后发生胆总管结石。5 例(6.3%)患者出现复发性胆囊结石(3 例行胆囊切除术,2 例行胆囊造瘘术)。
对于高危手术患者,PCCL 是一种可行的治疗有症状胆囊结石的方法。即使是在先前胆囊切除术失败的患者中,该手术也具有较高的技术成功率。大多数患者(77.3%)在术后避免了与胆囊结石相关的并发症。